Google may be the search engine leader and a heavyweight in the mobile/electronics arena, but the tech giant has been in a sticky situation as of late with antitrust settlements. 

Only days ago, it was announced that Google had set aside $500 million USD for antitrust settlements from a pending U.S. federal antitrust inquiry. The U.S. Department of Justice is launching an investigation, and according to Google, this chunk of change for settlements dropped its first-quarter net income to $1.8 billion.

Now, reports state that Google is close to settling an investigation that the U.S. Food and Drug Administration launched against the tech leader last year. The FDA looked into whether Google knowingly accepted pharmacy ads online that break the law. According to reports, Google was making hundreds of millions of dollars from these online pharmacy ads, which allegedly sold expired or counterfeit drugs, and/or sold these drugs without a valid prescription, but it is currently unclear which, if both, are true.  

Last year, Google made changes to its online pharmacy ad policies after the FDA launched the investigation.